Article
Correlation of genotype, phenotype, and mRNA expression of CYP2D6 and CYP2C19 in peripheral blood leukocytes (PBLs).
International journal of clinical pharmacology and therapeutics - 1 Feb 2014
Kuhlmann Jan B, Wensing Georg, Kuhlmann Jochen
Abstract excerpt
INTRODUCTION: The genetic polymorphism of drug metabolizing enzymes of the cytochrome P450 (CYP) families, especially CYP2D6 and CYP2C19, is the most important cause of variable responses of many drugs. Enzyme activity ranges from complete deficiency, so called poor metabolizers (PMs), to an ultrafast metabolism. While PMs and extensive metabolizers (EMs) can be well distinguished by genotyping, phenotyping is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
